US Tweaks Timeline for Chinese Float Glass Trade Probe
Published Date: 11/24/2025
Notice
Summary
The U.S. International Trade Commission is updating the timeline for its investigation into float glass products from China and Malaysia. This affects companies involved in importing or selling these glass products, with new deadlines for reports, hearings, and final decisions set between December 2025 and February 2026. The changes come after a government funding pause delayed the process, so everyone should get ready for the fresh schedule and upcoming money-impacting decisions.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12996 — Choline Salts From China; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations
The U.S. is launching investigations to see if cheap choline salts from China are hurting American businesses by being sold unfairly or getting government help. If the claims are true, extra taxes might be added to these imports to protect U.S. companies. The first big decision is due by August 10, 2026, so things are moving fast!
2026-12850 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint about certain skin treatment devices possibly breaking import rules. Companies from several countries, including the U.S., Israel, and Europe, are involved. The Commission wants your thoughts on how this might affect the public before deciding on possible bans or restrictions, with a 60-day review period ahead.
2026-12777 — N-Cyclohexylbenzothiazole-2-Sulfenamide (“CBS”) From China; Determinations
The U.S. government found that imports of a chemical called CBS from China might be hurting American businesses by being sold too cheaply or getting unfair help from the Chinese government. Because of this, they’re starting a big investigation to decide if special taxes or rules should be put in place. This affects companies that make or use CBS and could lead to changes in prices or import rules soon.
2026-12768 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint about certain adjustable child carriers and their parts, claiming some imports and sales might break trade rules. They want the public to share thoughts on how this could affect everyone, especially families and businesses. This could lead to new rules stopping some products from being sold in the U.S., so keep an eye out for updates soon!
2026-12651 — Certain Frozen Fish Fillets From Vietnam; Determination
The U.S. International Trade Commission decided to keep the extra taxes on frozen fish fillets from Vietnam because removing them could hurt American fish businesses. This means importers will still pay these duties, helping protect U.S. jobs and companies. The decision was finalized in June 2026 and affects anyone buying or selling these fish fillets in the U.S.
2026-12710 — Agency Information Collection Activities: Submission for OMB Review; Renewal of Generic Clearance; Comment Request
The U.S. International Trade Commission is asking to renew its permission to collect info for trade investigations for another three years. This affects businesses and groups involved in trade cases like tariffs and import rules. If you have thoughts, you’ve got until July 24, 2026, to share them—no cost changes, just keeping things running smoothly!
Previous / Next Documents
Previous: 2025-20765 — Agency Information Collection Activities; Reinstatement; Lien Notice (CBP Form 3485)
U.S. Customs and Border Protection is bringing back the Lien Notice form (CBP Form 3485) and wants your feedback by December 24, 2025. This form helps track claims on goods, so businesses and agencies dealing with imports should pay attention. No new fees are involved, but timely comments will keep the process smooth and clear!
Next: 2025-20767 — Intercept Pharmaceuticals, Inc., et al.; Withdrawal of Approval of New Drug Application for OCALIVA (Obeticholic Acid) Tablets, 5 Milligrams and 10 Milligrams, and Three Abbreviated New Drug Applications for Obeticholic Acid Tablets, 5 Milligrams and 10 Milligrams
The FDA is officially pulling the approval for OCALIVA tablets (5 mg and 10 mg) and similar versions from three other companies, effective November 24, 2025. This affects patients, doctors, and pharmacies who use or sell these drugs, meaning they’ll need to find alternatives soon. The companies themselves asked for this change, so no surprise fees or penalties are involved.